Furthermore, this treatment eliminated downstream signaling of inflammatory proteins, such as TLR4, in the spinal cord, and reduced levels of TNF-alpha and Bcl-2 expression in the ALS animal model [9]. This evidence concerns the gene BCL2 and amyotrophic lateral sclerosis.